Table 5 Comorbid conditions, stratified by last observed biochemical control
From: The association between biochemical control and cardiovascular risk factors in acromegaly
Controlled N = 79; 65.8% | Uncontrolled N = 41; 34.2% | All N =120 | ||
|---|---|---|---|---|
Cardiovascular | ||||
Hypertension | n | 33 | 24 | 57 |
(%) | (41.8) | (58.5) | (47.5) | |
Diabetes mellitus | n | 20 | 17 | 37 |
(%) | (25.3) | (41.5) | (30.8) | |
Left ventricular hypertrophy | n | 9 | 4 | 13 |
(%) | (11.4) | (9.8) | (10.8) | |
Cardiomyopathy or heart failure | n | 3 | 3 | 6 |
(%) | (3.8) | (7.3) | (5.0) | |
Other | ||||
Sleep apnea | n | 16 | 11 | 27 |
(%) | (20.3) | (26.8) | (22.5) | |
Colonic polyps or colon cancer | n | 16 | 8 | 24 |
(%) | (20.3) | (19.5) | (20.0) | |
Visual field defects | n | 14 | 6 | 20 |
(%) | (17.7) | (14.6) | (16.7) | |